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A 6-month randomised controlled trial investigating effects of
Mediterranean-style diet and fish oil supplementation on dietary
behaviour change, mental and cardiometabolic health and health-related
quality of life in adults with depression (HELFIMED): study protocol
Abstract
Background: Modern diets, characterised by excess consumption of processed foods, are accompanied by an
epidemic of chronic diseases. Cardiovascular disease and depression carry a large burden of disease and often
occur together. Poor dietary patterns have been identified as an independent risk factor for depression while
healthy diets with minimally processed food are protective. Traditional Mediterranean diets have been shown
to reduce risk of cardiovascular disease; however there is a need for clinical trials in people with depression.
This paper reports the study protocol of a Mediterranean-style diet intervention conducted in adults with self-
reported depression. Methods/design: HELFIMED is a parallel 6-month randomised controlled trial
investigating whether dietary patterns can be improved in people with depressive symptoms and whether
healthier diet combined with fish oil supplementation can improve mental and cardiometabolic health and
quality of life. Adults aged 18-65 years with selfreported depressive symptoms over the previous two months
(N = 163) were block-randomised on age and gender between May 2014 and June 2015 to receive nutrition
education, food hampers, fortnightly cooking workshops based on Mediterranean-style dietary principles for
3 months and fish oil supplementation for 6 months, or to attend fortnightly social groups (control group) for
3 months. All participants completed mental health (DASS and PANAS), quality of life, dietary and shopping
and budgeting questionnaires and provided anthropometric measurements, blood and urine samples at
baseline, 3 and 6 months. Additionally the treatment group attended focus groups at 3 and 6 months. Primary
and secondary outcomes will be analysed using linear mixed modelling and correlations will investigate
associations between improved health outcomes and subjective/objective measures of improved diet/
nutritional status.Discussion: This study will contribute causal evidence to prior observational and
longitudinal studies that have shown associations between Mediterranean diet and mental health. The results
will inform public health and clinical strategies for treatment of depression and comorbid cardiometabolic risk
factors.
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Abstract
Background: Modern diets, characterised by excess consumption of processed foods, are accompanied by an
epidemic of chronic diseases. Cardiovascular disease and depression carry a large burden of disease and often occur
together. Poor dietary patterns have been identified as an independent risk factor for depression while healthy diets
with minimally processed food are protective. Traditional Mediterranean diets have been shown to reduce risk of
cardiovascular disease; however there is a need for clinical trials in people with depression. This paper reports the study
protocol of a Mediterranean-style diet intervention conducted in adults with self-reported depression.
Methods/design: HELFIMED is a parallel 6-month randomised controlled trial investigating whether dietary patterns
can be improved in people with depressive symptoms and whether healthier diet combined with fish oil
supplementation can improve mental and cardiometabolic health and quality of life. Adults aged 18–65 years with self-
reported depressive symptoms over the previous two months (N = 163) were block-randomised on age and gender
between May 2014 and June 2015 to receive nutrition education, food hampers, fortnightly cooking workshops based
on Mediterranean-style dietary principles for 3 months and fish oil supplementation for 6 months, or to attend
fortnightly social groups (control group) for 3 months. All participants completed mental health (DASS and PANAS),
quality of life, dietary and shopping and budgeting questionnaires and provided anthropometric measurements, blood
and urine samples at baseline, 3 and 6 months. Additionally the treatment group attended focus groups at 3 and
6 months. Primary and secondary outcomes will be analysed using linear mixed modelling and correlations will
investigate associations between improved health outcomes and subjective/objective measures of improved diet/
nutritional status.
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Discussion: This study will contribute causal evidence to prior observational and longitudinal studies that have shown
associations between Mediterranean diet and mental health. The results will inform public health and clinical strategies
for treatment of depression and comorbid cardiometabolic risk factors.
Trial registration: Australian New Zealand Clinical Trials Register (ACTRN12614000438651). Trial registration date:
23rd April 2014.
Keywords: Mediterranean diet, Depression, Cardiometabolic health, Quality of life, Study protocol
Abbreviations: ADHD, Attention deficit hyperactivity disorder; apoA1, Apolipoprotein A1; apoB, Apolipoprotein
B; AQoL, Assessment of quality of life; DASS, Depression anxiety stress scale; DHA, Docosahexaenoic acid;
EPA, Eicosapentaenoic acid; HELFIMED, Healthy eating for life with a MEDiterranean-style diet; n-3
PUFAs, Omega-3 polyunsaturated fatty acids; PANAS, Positive and negative affect scale; SDQ, Simple dietary
questionnaire
Background
Unhealthy food consumption has worsened around the
globe, including developed countries, as evidenced by a
recent systematic assessment of dietary quality in 187 coun-
tries from 1990–2010 [1]. Diet-related health burdens have
resulted in a major global shift towards an epidemic of
non-communicable chronic disease [2]. Despite advances
in drug treatments, the World Health Organization pre-
dicted that mental disorders, specifically depression, and
heart disease will be the second and third leading causes of
disability and will be major contributors to the global bur-
den of disease by 2030 [3]. Moreover there is evidence that
physical health conditions, such as cardiovascular disease
and metabolic syndrome, and mental illness including
depression share similar underlying mechanisms such as
chronic inflammation [4–7].
Mediterranean-style diets, characterised by high con-
sumption of vegetables, fruit, legumes, olive oil, fish,
cereals, nuts and seeds, moderate consumption of red
wine with meals, and low intakes of processed food, red
meat and vegetable oils, are rich in bio-protective nutri-
ents, fibre, healthy fats, antioxidants and polyphenolic
compounds [8, 9]. Accordingly, these diets have been
associated with improved cardiovascular health and de-
creased mortality, with protective benefits for cancer,
obesity, cardiovascular disease and diabetes [10, 11], and
this has been supported by intervention studies [12, 13].
Mechanisms of action that have been identified via meta-
analysis of studies comparing the Mediterranean diet with
low-fat diet in overweight individuals at increased risk of
cardiovascular disease include reduced total and LDL
cholesterol, increased HDL cholesterol, and reduced
inflammation, fasting glucose and insulin [13].
In comparison to focus on physical health problems, rela-
tively little attention has been given to the implications of
detrimental modern dietary patterns for society’s growing
mental health problems, despite the important structural
and functional roles of nutrients in the brain [14].
Nutritional supplement interventions have shown some
promise in improving cognitive function and mental health.
In particular, considerable research has in recent decades
investigated benefits of omega-3 polyunsaturated fatty acids
(n-3 PUFAs) for mental health across the lifespan including
attention deficit hyperactivity disorder (ADHD) and learn-
ing difficulties, uni- and bipolar depression, schizophrenia
and mild cognitive impairment [15, 16]. However, a range
of nutrients and other food components (e.g. polyphenols,
fibre) provided by a whole food, Mediterranean-style diet
are important for physical and mental health. There is
increasing evidence that diet not only plays a crucial role in
gut health but also subsequently on brain function via the
gut-brain axis [14, 15]. While there is converging evidence
showing an important role for individual nutrients and diet-
ary components in brain function, there is a dearth of
research investigating synergistic actions of nutrients and
benefits of whole diets for mental health [14].
Correlational and longitudinal population studies have
reported that healthy dietary patterns are associated with
lower incidence of depression while unhealthy dietary
patterns are associated with higher risk [17]. The Medi-
terranean diet has been associated in case-control, longi-
tudinal cohort and cross-sectional studies with reduced
risk of depression [18]. However a very limited number
of dietary interventions has investigated mental health
benefits with urgent calls for more research in this area
[19, 20]. The PREDIMED study recruited adults with
high risk for cardiovascular disease and allocated partici-
pants to one of two Mediterranean diet groups supple-
mented with nuts or olive oil or a control group that
was allocated to a low-fat diet [21]. Secondary analysis at
3-year follow-up identified that incidence of depression
was inversely associated with the Mediterranean diet
plus nuts group although non-significantly. This finding
became statistically significant when restricted to partici-
pants with Type 2 diabetes mellitus, showing a 41 %
relative reduction in depression risk. Further per
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protocol analysis revealed that strongest adherence to
Mediterranean diet was associated with lowest depres-
sion risk [22]. In a weight-loss intervention, improve-
ments in diet quality over six months in both the
Mediterranean diet intervention group and control diet
based on American Heart Association guidelines were
associated with over 50 % reduction in Beck Depression
Inventory (BDI) scores [23]. Additional longitudinal ana-
lyses adjusting for confounders showed improvements in
BDI scores to be mediated by higher fibre, folate and
magnesium consumption, however only folate remained
as a significant mediator after adjustment for weight-loss
[23]. Stahl et al. recruited older adults at risk for major
depression to investigate the efficacy of problem solving
for reducing major depressive episodes and used a diet-
ary coaching arm, based on US dietary guidelines, as a
control [24]. Contrary to their expectations, they found
that the dietary arm decreased depressive symptoms by
40–50 %, which was maintained over 2 year follow-up,
and that the rate of progression to major depression was
greatly reduced compared to population norms. Interest-
ingly, medical comorbidities were one of the predictors
of transition to major depression. Based on this evidence
there is a need for randomised controlled trials to recruit
people with depression to investigate whether dietary
intervention, with a focus on Mediterranean-style diet,
can reduce depressive symptoms and improve wellbeing.
This study aims to investigate the effects of a 6-month
Mediterranean-style dietary intervention combined with
fish oil supplementation on mental health, cardiometabolic
health and health-related quality of life in people with self-
reported depression. The current paper provides a compre-
hensive outline of the study protocol and measures used.
To our knowledge this will be one of the first randomised
controlled trials worldwide to investigate the benefits of
Mediterranean-style diet on mental health in people with
self-reported depression, with one other Australian study
underway [25]. These studies will help to address an im-
portant gap in the evidence base for addressing the growing
global public health challenges associated with depression
and cardiovascular disease.
Method/design
Aims
The aims of the study, “Healthy Eating for LiFe with a
MEDiterranean-style diet” (HELFIMED) are to (a)
encourage participants to adopt a healthy whole food,
Mediterranean-style diet via provision of cooking work-
shops supplemented by recipe books and cooking vid-
eos, food hampers and nutrition education; and (b)
measure benefits of improved diet and fish oil supple-
mentation for cardiometabolic and mental health and
health-related quality of life. Secondary aims are to
investigate whether (a) improved self-reported diet and
dietary biomarkers (carotenoids, urinary sodium and po-
tassium), and erythrocyte (red blood cell) n-3 PUFA
levels from fish oil supplementation are associated with
improved mental and/or cardiometabolic health out-
comes; and (b) outcomes are mediated by inflammatory
and oxidative markers. Depression is a risk factor for
developing cardiovascular disease, and furthermore, in-
creases mortality from cardiovascular disease [26]. This
may be attributed to common risk factors including poor
diet and low n-3 PUFA levels which are associated with
both conditions. Given the alarmingly low n-3 PUFA
intake in western diets [27] and their importance for
cardiovascular and mental health, fish oil supplementa-
tion was included in this study. Indeed baseline analysis
from this cohort and another cohort of people with
schizophrenia identified an average omega-3 index
(eicosapentaenoic acid; EPA + docosahexaenoic acid;
DHA) [28] of 3.95 (SD = 1.06) percent of red blood cell
membranes [29] which is in the range that confers high-
est risk of mortality from cardiovascular disease (≤4 %),
and is even lower than the average low level of 5 % in
the Australian population [30, 31].
Participants and study procedure
Adults aged 18–65 years (N = 163) with self-reported de-
pression, shown to have a moderate level of agreement
with diagnosed depression [32], were recruited from the
community via newspaper advertisements, television and
radio interviews, social media, and a market research
agency for a 6-month parallel randomised controlled
intervention with data collected at 0, 3 and 6 months.
Ethics approval was provided by the Human Research
Ethics Committee of the University of South Australia
(registration no. 0000032674) and all participants pro-
vided written informed consent. According to Cohen’s
power analyses, at least 60 people in each group are
required to detect a medium effect size with 80 % power;
therefore allowing for an estimated 30 % dropout rate
the target total sample size was N = 172. A CONSORT
flow chart of participants through the study is provided
in Fig. 1.
Interested volunteers were screened via phone for the
following eligibility criteria: 18–65 years old; diagnosed
depression or self-reported depressive symptoms over
the past 2 months or more; not taking fish oil supple-
ments; and a low diet quality score (<70 % of maximum
score) on a 13-item dietary screening tool developed for
this study, assessing compliance with Australian dietary
guidelines. This was to exclude people already consum-
ing a healthy diet and therefore with less room for im-
provement in diet quality. Eligible participants were
provided with detailed study information and consent
form via post or email, and subsequently scheduled to
attend a baseline appointment upon providing study
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consent. If participants were receiving treatment for
their depressive symptoms they were asked to continue
what they were doing. Participants who had just started
a new treatment protocol at recruitment (anti-depres-
sant medication and/or counselling or psychotherapy);
changed their treatment or were intending to change
their treatment were delayed in beginning their study
participation until they had been undergoing their new
treatment protocol for a month. Participants were asked
not to start any new treatment or make other lifestyle
changes during the study. Prior to attending baseline as-
sessments, participants were randomised by a team
member not involved in screening or data collection
using the process of minimisation [33], blocked on age
and gender, to the intervention or control group. Data
collectors and participants were blinded to the treatment
allocation until after baseline assessments were com-
pleted. Team members conducting data analysis were
not involved in data collection, and treatments are
blinded until after data are analysed.
All participants attended the Sansom Institute for
Health Research clinic at the City East campus of the
University of South Australia at baseline, 3 and 6 months
for assessments following an overnight fast (water
allowed) for blood and urine samples, blood pressure
and anthropometric measurements. They were then
provided with a light breakfast and asked to complete
questionnaires. Following each round of assessments,
participants were given a 3-day food diary and instruc-
tions on how to complete it. They were provided with a
reply-paid envelope to return the food diaries on com-
pletion. All assessments were recorded in individual
Case Report Forms according to Good Clinical Practice
guidelines (Declaration of Helsinki).
Intervention protocol
For the first three months of the study, the intervention
group received a nutrition education workshop and then
six fortnightly group cooking classes, supplemented by four
shopping and budgeting education activities during cooking
workshops, and recipes and cooking demonstration videos
on the HELFIMED.org website. The nutrition education
session was led by a nutritionist and dietitian utilising an
interactive quiz, PowerPoint presentation on health and the
Fig. 1 Consort flow chart
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Mediterranean diet and food modelling activity based on
the Dietary Guidelines for Australians with modifications
according to Mediterranean-style dietary principles (i.e.
extra virgin olive oil as the principle source of fat; legumes
and fish as primary sources of protein). For the cooking
workshops, participants worked in small groups of 2–4 to
prepare and cook a supplied recipe, within a small work-
shop setting (2–12 participants) guided by two workshop
facilitators. These were conducted in a commercial kitchen
at the university, and after preparing the dishes participants
ate them together. At each cooking workshop participants
received a food hamper that was matched to recipe
cooked, containing extra virgin olive oil (donated by
Cobram Estate), tinned legumes, tomatoes and tuna (sup-
plied by Simplot), and seasonal fruit, vegetables, and
mixed nuts (supplied wholesale by Tony & Marks Fresh
Fruiterers). If participants were unable to attend a cooking
workshop in a given fortnight, they were able to collect
their food hamper. They were also provided with 2 fish oil
capsules per day (grade EPAX 1050 TG each containing
450 mg DHA and 100 EPA per capsule; donated by Epax)
for the whole 6 months. The HELFIMED protocol, includ-
ing nutrition education, cooking workshops and food
hampers, was successfully trialed previously in people with
serious mental illness [34].
Control group protocol
The control group attended fortnightly social groups (e.g.
sharing holiday stories, playing games, doing personality
tests, watching a movie with discussion, book club) during
the first three months as a control for the social compo-
nent of the cooking workshops that can help to improve
depressive symptoms. They were provided with free
double movie passes as a thank you for completing each
round of assessments. On completion of their final round
of assessments they were given 3 months’ supply of fish
oil, a copy of the recipe book provided to the treatment
group and attended a nutrition education session.
A clinical Psychologist met with all team members
undertaking data collection, cooking workshops and
social groups to provide advice and training on how to
handle any difficult situations, and was available for
referral of participants if counselling was required.
Assessments
Baseline assessments included fasted blood samples,
weight, height, waist circumference and blood pressure,
and questionnaires included the Depression Anxiety
Stress Scale (DASS-21) [35], Assessment of Quality of
Life (AQoL)-8D scale (primary outcomes) [36]; Positive
and Negative Affect Scale (PANAS) [37], Simple Dietary
Questionnaire (SDQ), Mediterranean diet questionnaire
[38] and shopping and budgeting questionnaire. A back-
ground questionnaire measured potential covariates: age,
gender, socio-economic status, education level (1 = com-
pleted primary school; 8 = postgraduate degree), house-
hold income, sedentary time and physical activity (each
calculated as total minutes per week), sleeping difficul-
ties (how many hours sleep on average on weeknights
and weekends; and whether or not they consider sleep
to be a problem – yes/no/don’t know), smoking status
(1 = never smoked; 5 = smoke daily), and frequency of
consuming >2 alcoholic drinks per day (1 = never/rarely;
5 = daily). Socioeconomic status was determined from
participant postcodes using deciles of the Socio-
Economic Indexes For Areas, a ranking of Australian
neighbourhood disadvantaged and advantage, based on
census data for variables such as education, income and
occupation status [39]. Physical activity and sitting time
were measured using two questions adapted from the
short form of the validated International Physical Activ-
ity Questionnaire (IPAQ) [40].
Anthropometric measures
Height, weight, waist and hip circumference measure-
ments were conducted by trained personnel according
to International Standards for Anthropometry and Kin-
esiology (ISAK) guidelines [41]. Height was measured
using a SECA ce0123 portable stadiometer to the near-
est 0.1 cm, using the free standing stature technique,
whereby the participant’s head was aligned in the
Frankfort plane and the participant was instructed to
take and hold a deep breath while the measurement
was taken. Weight was measured by using TANITA™
UM-021w calibrated digital scales to the nearest 0.1 kg.
Height and weight were used to calculate Body Mass Index
(BMI =mass (kg)/height (m2)). Waist measurements were
taken at the point of the visual narrowing, and hip mea-
surements were taken at the furthest protruding point
of the buttocks, using a Luftkin Executive Thinline
(W606PM) 2 m tape. Waist and hip measurements
provide a measure of central adiposity, which may be a
risk factor for CVD [42]. Two repeat measures were
taken for all measurements, and the mean was calcu-
lated. If the measurements exceeded 0.5 cm, a third
measurement was taken and mean of the three mea-
surements was calculated.
Blood pressure
Resting blood pressure was measured using an automated
Omron sphygmomanometer (Model HEM-7000-C1L).
The participant was seated for 5–10 min prior to taking
two measurements, with one minute between measure-
ments. If the difference between the first two measure-
ments exceeded 5 mmHg for either systolic or diastolic
pressure, up to two subsequent measurements were taken
to obtain two measurements within 5 mmHg.
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Blood samples
Fasting blood samples were collected by trained phle-
botomists, and taken to SA Pathology for analysis or
spun by low speed centrifugation, aliquoted into 1 ml
tubes and stored at −80 °C for analysis by specialised
laboratories.
Apolipoprotein B (apoB) and AI (apoA1) were mea-
sured to assess cardiovascular health. Apolipoproteins
are lipid-binding proteins containing cholesterol and
lipids. ApoB is a measure of LDL-cholesterol while
apoA1 is an indicator of the number of HDL particles.
The ratio of apoB/apoA1 has emerged as a strong diag-
nostic marker of metabolic syndrome [43] and next to
smoking as the strongest predictor of cardiovascular
disease (specifically risk of myocardial infarction) [44]
and was therefore the third primary outcome to assess
cardiovascular effects of the intervention. Fasted blood
samples were collected in 8 ml serum tubes, and were
transported to SA pathology on ice for analysis within
two hours of collection.
Omega-3 fatty acids: Fasted blood samples were used
to measure erythrocyte levels of n-3 PUFAs in order to
assess the direct contribution of fish oil supplementation
to any improved outcome measures. Fasted blood sam-
ples were collected in 6 ml EDTA tubes, red blood cells
were separated from plasma by low speed centrifugation
and packed red blood cells were stored in 1 ml micro
tubes at -80C until analysis. Erythrocyte samples were
thawed and prepared for fatty acid analysis according to
Swierk et al. [31] using the direct transesterification
procedure according to Lepage and Roy [45]. Samples
were analysed by flame-ionisation gas chromatography
(model GC-17A, Shimadzu) using a 50 m × 0.25 mm
internal diameter capillary column. One microlitre of
the sample was auto-injected into the column, and in-
dividual fatty acids were quantified using the Shimadzu
analysis software (Class-VP 7.2.1 SP1, USA). Fatty acid
peaks were identified by comparison with known fatty
acid standards and quantitated by comparison to the 21:0
internal standard (Nu-chek and Sigma).
Carotenoids are a group of dietary antioxidant com-
pounds that have been identified as being higher in core
components of the Mediterranean diet including certain
vegetables, fruit and extra virgin olive oil [46]. These will
be measured in blood plasma to provide an objective in-
dicator of increased intake of fruits, vegetables and extra
virgin olive oil, and enable correlation with improved
outcome measures. Fasting blood samples are collected
in evacuated containers with EDTA then wrapped in
aluminium foil and kept away from direct light. Centri-
fugation of vacutainers for 10 min (1300 × g, 4oC) is
done within 1 h of collection to separate plasma from
whole blood. Plasma samples are aliquoted into amber
vials and stored at −80 °C until analysis. Methods for
extraction of carotenoids and preparation of internal
standards, external standards, secondary calibrator and
plasma samples are based on Karppi et al. [47]. Varia-
tions to these methods include the use of argon to
evaporate samples prior to reconstitution, and the High
Performance Liquid Chromatography (HPLC) model
used for analyses is an Agilent 1100 with Kinetex 5 μm
C18 100 Å columns (250 × 4.6 mm).
Antioxidant and inflammatory markers will be mea-
sured in serum. Inflammation and oxidative stress can
contribute to the pathophysiology of mood disorders
[4, 5, 14, 48] and are associated with diet [48–50].
With blood samples we will investigate the impact of diet
on high sensitivity C-Reactive protein, interleukins 1 and
6, and F2 isoprostane biomarkers and whether these bio-
markers mediate any improved outcomes.
Urine samples
Participants provided a fasted 10 ml urine sample upon
arrival, which was taken to SA Pathology for analysis.
Urine samples were used to measure the ratio of sodium
to potassium intake, which may be related to establish
risk factors such as hypertension, obesity and unhealthy
eating for cardiovascular diseases and mortality [51–54].
Sodium/potassium ratio can also be an indicator of
current food intake, with sodium reflecting intake of
processed foods, and potassium reflecting intake of fruit,
vegetables and whole foods generally [52, 54–56]. The
cut-off point of less than or equal to one has been
recommended [52]. A ratio of one or more may indicate
increased risk of high blood pressure [57].
AQoL-8d
The AQoL-8D is a 35-item questionnaire that is used to
measure quality of life. The 35 items load onto eight di-
mensions, of which three represent physical domains of
quality of life (independent living, pain and senses) and
five represent psychological domains (happiness, self-
worth, coping, relationships, mental health). These load
onto two super dimensions (physical and psycho-social).
The scores from each dimension are further combined
to create a final AQoL-8D utilities score for use in eco-
nomic evaluation, which will be conducted in this study
to measure the cost effectiveness of the program. The
AQoL-8D has good validity and internal consistency
with alpha coefficients of 0.89-0.96 [36].
DASS-21
The DASS is a 21-item self-report scale which provides
a measure of the level of negative emotional states of
depression, anxiety and stress [35]. It is a highly reliable
measure that shows high convergent validity and has
good internal consistency with a Cronbach alpha of
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0.82-0.93 [58, 59]. To identify degree of severity of these
emotional states, DASS-21 sub-scale severity ratings
were calculated based on the full DASS-42 severity
rating [35] – each scale is multiplied by two and divided
into severity categories to yield equivalent scores ranging
from 1 (normal) to 5 (extremely severe) for clinical
purposes.
PANAS
The PANAS is a 20-item scale measuring positive and
negative emotions. It has been validated and demon-
strates reliable psychometric properties, discriminant,
convergent and construct validity. The reliability (in-
ternal consistency) of the PANAS positive and negative
emotions scales were determined to be α = .89 and .85
respectively [37].
Shopping and budgeting questionnaire
An eighteen-question tailored shopping and budgeting
questionnaire was designed to measure knowledge of
nutrition, shopping and budgeting. This questionnaire
assessed specific topics that were covered in shopping
and budgeting education activities conducted during
cooking workshops, including knowledge of unit pricing,
supermarkets and other food stores (i.e. farmer’s mar-
kets), smart shopping, prices, budgeting, and reading
nutrition labels. This questionnaire will be assessed to
determine its psychometric properties.
Dietary questionnaires
A 14-item Mediterranean diet questionnaire was used to
assess level of adherence to the Mediterranean diet. Each
item is scored as 0 or 1, yielding a maximum score of 14
[38]. Higher scores on this questionnaire have been con-
sistently associated with reduced risk of mortality from
or incidence of cardiovascular disease [60]. A Simple
Dietary Questionnaire (SDQ) measured frequency of in-
take of a range of food groups including, for the purpose
of this study, vegetables, fruit, legumes, wholegrain
foods, takeaway foods (examples given were unhealthy
options such as burgers, chips, pizza), sweetened drinks,
unhealthy sweet and savoury snacks, fish, meat/chicken
and nuts. For each question a picture of the food is
provided and the portion size is described. For each food
group, frequency of intake was reported using six to nine
item response scales ranging from never/don’t eat to
consume seven or more serves per day. For vegetables,
fruit, wholegrain foods, takeaway foods, snack foods,
nuts, legumes, fish, and meat/chicken a further qualify-
ing question presented a range of different items asking
which of those had been consumed in the past two
weeks, in order to help prompt memory about foods
relevant to the previous item as well as measure dietary
variety. For the purpose of this study diversity of fruit
and vegetable consumption was measured due to the
variety of nutrients and phytonutrients provided by dif-
ferent fruits and vegetables. The SDQ will be validated
against 3-day food diaries which participants completed
on two week days and one weekend day.
Focus groups
The intervention group took part in focus groups of three
to eight participants at baseline, prior to the nutrition edu-
cation session, and again at 3 months. The purpose of
these was (a) at baseline to identify current nutrition
knowledge and food behaviours, enablers and barriers of
healthy food consumption, and goals for participation in
the program; and (b) at 3 months to identify behavioural
changes, whether health goals were achieved, barriers and
facilitators to achieving goals, and provide feedback and
evaluation of the program. Semi-structured interview
guides were used to allow for emerging themes to be ex-
plored. Focus groups were recorded, transcribed verbatim
and will be analysed using inductive and deductive ana-
lysis following the Framework Method [61, 62].
Statistical analysis
Analyses will be performed using IBM SPSS Version
21.0 for Windows (Chicago, IL, USA) Descriptive statis-
tics using mean and standard deviation or number/per-
centage for categorical variables will be used to provide
baseline demographics and measures, and t-tests or Chi
Square will be used to ensure that there are no differ-
ences between randomised groups. Empirical distribu-
tions will be examined for outcome variables and
variables that are not normally distributed will be either
transformed or categorised or analysed using non-
parametric methods if available. Where assumptions of
normality are met, linear mixed modelling will be used
to compare changes in the groups over time while
adjusting for covariates; this process includes all data
therefore allowing analysis on an intent-to-treat basis.
To investigate whether changed dietary patterns and
omega-3 fatty acid levels were associated with any posi-
tive outcomes in mental and/or cardiometabolic health,
changes in diet scores, sodium potassium ratio, caroten-
oids and omega-3 fatty acids will be entered into correl-
ation or regression analyses as appropriate with changes
in outcome scores/markers as dependent variables. Sec-
ondary sub-group analyses by depression severity (using
DASS categories [35]) will be conducted to determine if
the severity of depression has a modification effect on
the results. To investigate whether blood antioxidant
and inflammatory markers mediate relationships
between diet and improved outcomes, pathway models
will be fitted to the data with direct and indirect effects
tested for their statistical significance. Since these
models will involve change over time (growth curve)
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and pathway mechanisms, they will be performed using
advanced software tools such as Mplus developed by
Muthén and Muthén [63].
Discussion
Over three months the HELFIMED protocol provided
nutrition education and fortnightly cooking workshops
and nutrition education based on Mediterranean-style
dietary principles which will be followed up at 6 months
to investigate the sustainability of any dietary changes,
and to explore whether depressive symptoms, mental
health, health-related quality of life and cardiometabolic
health improved as a result of the intervention. Correla-
tions and/or regression analyses will determine the con-
tributions of dietary changes, carotenoids and omega-3
levels as a result of fish oil consumption to any im-
proved outcomes, and further investigate biochemical
markers as potential mediators of these changes over 3
and 6 months. Focus groups and evaluations will identify
barriers and enablers of eating healthy diets, and with
additional analysis will assist in measuring predictors of
retention and improvement to enable further identifica-
tion of successful program components for adopting a
healthy Mediterranean-style diet in people with depres-
sion and areas for improvement.
Strengths of the study include the randomisation and
controlling for the social component of the cooking
workshops and study involvement. The study is limited
in that double blinding was not possible and social desir-
ability responses cannot be ruled out. Additionally, the
study findings may be limited by using self-report de-
pression at recruitment, however self-report depression
has been shown to have a moderate level of agreement
with diagnosed depression [32]. This approach was used
to maximise recruitment in this population as many in-
dividuals with depression do not seek a diagnosis and
treatment [64].
This is one of the first randomised controlled trials
worldwide to investigate the effect of whole diet, specif-
ically Mediterranean-style diet, on mental health in
people with depression. If successful it will support the
body of epidemiological data indicating that Mediterra-
nean diet is protective against depression, and will have
highly significant implications for treatment and preven-
tion of this prevalent and disabling condition and its
substantial impact on the global burden of disease.
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